Skip to main content
NIH funding notice RFA-NS-19-016

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closed on April 15, 2020.

Posted
December 10, 2018
Close date
April 15, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,702,375 in first-year total cost, median $1,351,188.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-C (04)]1
  2. Special Emphasis Panel[ZNS1 SRB-M (10)]1

Most frequent institutions

  1. STANFORD UNIVERSITY1
  2. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under RFA-NS-19-016 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Home-based transcutaneous electrical acustimulation for abdominal pain1UG3NS115108-01A1CHEN, JIANDEUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$1,283,974ZNS1
2019Clinical Translation of Ultrasonic Ketamine Uncaging for Non-Opioid Therapy of Chronic Pain1UG3NS115637-01AIRAN, RAAG DWILLIAMS, NOLAN R.STANFORD UNIVERSITY, CA$1,418,401ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-NS-19-016: HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) | ScienceDex | ConductScience